Novartis Finalizes U.S. Manufacturing and R&D Expansion Plan With Seventh New Facility
April 30, 2026
April 30, 2026
BASEL, Switzerland, April 30 -- Novartis, a pharmaceutical company, issued the following news release:
* * *
Novartis finalizes US manufacturing and R&D expansion plan with seventh new facility
* At one-year mark, company has progressed all components of US investment plan to support delivery of innovative medicines to US patients
* New active pharmaceutical ingredients facility in North Carolina to enable end to end manufacturing for all a . . .
* * *
Novartis finalizes US manufacturing and R&D expansion plan with seventh new facility
* At one-year mark, company has progressed all components of US investment plan to support delivery of innovative medicines to US patients
* New active pharmaceutical ingredients facility in North Carolina to enable end to end manufacturing for all a . . .